ResearcherAzienda ULSS 9 ScaligeraNo recent work listed
Andrea Vincent Bonetti
Matched on ORCID iD 0000-0003-2329-6628; OpenAlex author ID A5084410786.
Their work
- Papers
- 6 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 1
2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper
Papers 6
- FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer. Last author DOI 10.1016/j.pan.2019.01.014↗
- Long-term survival in advanced pancreatic cancer. Last author DOI 10.1701/2932.29492↗
- Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice. Last author DOI 10.1701/2656.27239↗
- [La combinazione di gemcitabina e oxaliplatino (GEMOX) nel trattamento del carcinoma pancreatico in fase avanzata di malattia: le notizie sulla mia morte sono … Last author DOI 10.1701/2829.28584↗
- The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction. Last author DOI 10.1016/j.ejso.2015.12.015↗
- Management of advanced pancreatic cancer in daily clinical practice. Last author DOI 10.5301/tj.5000428↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Jacopo Giuliani · 6 shared papers, 2016–2019
- Paper FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer. DOI 10.1016/j.pan.2019.01.014↗
- Paper Long-term survival in advanced pancreatic cancer. DOI 10.1701/2932.29492↗
- Paper Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clini… DOI 10.1701/2656.27239↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.